J. Biol. Chem., Vol. 266, Issue 27, 18299-18307, Sep, 1991
Identification of the glucocorticoid suppressible mitogen from rat hepatoma cells as an angiogenic platelet-derived growth factor A-chain homodimer
T Haraguchi, DB Alexander, DS King, CP Edwards and GL Firestone
Department of Molecular and Cell Biology, University of California, Berkeley 94720.
We have previously shown that BDS.1 rat hepatoma cells are hypersensitive
to the antiproliferative effects of glucocorticoids, and secrete a
glucocorticoid suppressible mitogenic activity (denoted GSM). Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis revealed that GSM
purified to near homogeneity migrated as a 28-kDa protein under nonreducing
conditions and as a single 15-kDa polypeptide in the presence of sulfhydryl
reducing agents suggesting a homodimeric structure. Anti-platelet-derived
growth factor (PDGF) A-chain specific antibodies selectively immunodepleted
the mitogenic activity which can be extracted from nonreducing gels in the
26-30-kDa fraction and, in Western blots, recognized the 15-kDa reduced
form of GSM. Western blot analysis further showed that dexamethasone
suppressed the level of secreted PDGF A-chain protein in BDS.1 cells but
not in glucocorticoid receptor-deficient hepatoma cells. Northern blots
revealed that dexamethasone reduced expression of the PDGF A-chain 2.3- and
1.7- kilobase transcripts in proportion to the level of detectable PDGF-AA
protein. Similarly to PDGF-AA, the hepatoma cell-derived GSM has a potent
angiogenic activity. Taken together, our results demonstrate that the
predominant glucocorticoid suppressible mitogen secreted from rat hepatoma
cells is a PDGF A-chain homodimer and suggest that in vivo glucocorticoids
may potentially regulate hepatoma growth by modulating PDGF-stimulated
tumor vascularization.